Subjective sleep disturbance in Chinese adults with epilepsy: Associations with affective symptoms

Shen, Yeru; Zhang, Mengmeng; Wang, Yu; Wang, Lanlan; Xu, Xiangjun; Xiao, Gairong; Chen, Jing; Zhang, Ting; Zhang, Nong

doi:10.1016/j.eplepsyres.2017.06.014

Cited by 35 publications

(21 citation statements)

References 64 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The ISI could identify insomnia in 19% of all epilepsy patients. Those epilepsy patients with insomnia were significantly more often treated with lamotrigine than those without insomnia [66]. In a prospective longitudinal study comprising 95 patients with unclassified epilepsies, 65,5% suffered from mild to moderate, and 28,9% from severe insomnia.…”

Section: Insomnia In Epilepsymentioning

confidence: 99%

Insomnia in neurological diseases

Mayer

Happe²,

Evers

et al. 2021

Neurol. Res. Pract.

View full text Add to dashboard Cite

Insomnia is defined as difficulties of initiating and maintaining sleep, early awakening and poor subjective sleep quality despite adequate opportunity and circumstances for sleep with impairment of daytime performance. These components of insomnia – namely persistent sleep difficulties despite of adequate sleep opportunity resulting in daytime dysfunction - appear secondary or co-morbid to neurological diseases. Comorbid insomnia originates from neurodegenerative, inflammatory, traumatic or ischemic changes in sleep regulating brainstem and hypothalamic nuclei with consecutive changes of neurotransmitters. Symptoms of neurological disorders (i.e motor deficits), co-morbidities (i.e. pain, depression, anxiety) and some disease-specific pharmaceuticals may cause insomnia and/or other sleep problems.This guideline focuses on insomnias in headaches, neurodegenerative movement disorders, multiple sclerosis, traumatic brain injury, epilepsies, stroke, neuromuscular disease and dementia.The most important new recommendations are: Cognitive behavioral therapy (CBTi) is recommended to treat acute and chronic insomnia in headache patients. Insomnia is one of the most frequent sleep complaints in neurodegenerative movement disorders. Patients may benefit from CBTi, antidepressants (trazodone, doxepin), melatonin and gaba-agonists. Insomnia is a frequent precursor of MS symptoms by up to 10 years. CBTi is recommended in patients with MS, traumatic brain injury and. Melatonin may improve insomnia symptoms in children with epilepsies. Patients with insomnia after stroke can be treated with benzodiazepine receptor agonists and sedating antidepressants. For patients with dementia suffering from insomnia trazodone, light therapy and physical exercise are recommended.

show abstract

Section: Insomnia In Epilepsymentioning

confidence: 99%

Insomnia in neurological diseases

Mayer

Happe²,

Evers

et al. 2021

Neurol. Res. Pract.

View full text Add to dashboard Cite

show abstract

“…In contrast, it is increasingly clear that anxiety is negatively related to sleep quality. For example, higher anxiety is an important predictor of poor sleep quality, more insomnia symptoms, and longer sleep onset time [26,27]. Notably, higher anxiety predicted lower sleep quality among individuals during the COVID-19 [2].…”

Section: Introductionmentioning

confidence: 99%

Perceived stress and sleep quality among the non-diseased general public in China during the 2019 coronavirus disease: a moderated mediation model

et al. 2021

View full text Add to dashboard Cite

Background: The 2019 coronavirus disease (COVID-19) has spread worldwide, and its associated stressors have resulted in decreased sleep quality among front-line workers. However, in China, the general public displayed more psychological problems than the front-line workers during the pandemic. Therefore, we investigated the influence of perceived stress on the sleep quality of the non-diseased general public and developed a moderated mediation model to explain said relationship. Methods: Questionnaire-based surveys were conducted online from February 18e25, 2020 with 1630 Chinese participants (aged 18e68 years). Results: Around one-third (36.38%) of participants were poor sleepers during the COVID-19 pandemic. Moreover, higher perceived stress was significantly associated with higher anxiety levels, which, in turn, was associated with lower sleep quality. Self-esteem moderated the indirect effect of perceived stress on sleep quality through its moderation of the effect of perceived stress on anxiety. This indicated that the mediation effect of anxiety was stronger in those with low levels of self-esteem than in those with high levels of self-esteem. Conclusions: These findings suggest that both the sleep quality and perceived stress levels of the nondiseased general public required attention during the COVID-19 pandemic. Our findings also identify personality characteristics related to better sleep quality, demonstrating the important role of selfesteem in environmental adaptation.

show abstract

“…Use of other, more comprehensive, screeners of sleep quality (e.g. Pittsburgh Sleep Quaity Index [15,16]) may be indicated. Detection of sleep and/or mood disturbance in patients with epilepsy with subjective memory complaints may indicate pragmatic treatment targets.…”

Section: Discussionmentioning

confidence: 99%

“…It may therefore be sensible to screen for sleep and mood disturbance, along with measures of metamemory, in patients with epilepsy. Sleep disturbance and subjective sleep complaints are recognised to be frequent in patients with epilepsy [13][14][15][16] and may impact quality of life more than seizure control in the short term [17].…”

Section: Introductionmentioning

confidence: 99%

Cognitive Symptoms in Patients with Epilepsy: Role of Sleep and Mood Disturbance

Bm¹,

Elhadd²,

Larner³

2019

J Sleep Disord Ther

View full text Add to dashboard Cite

Study background: Complaints of sleep disturbance are frequently encountered in patients with epilepsy, as are subjective memory complaints. Since the former may contribute to the latter, identification of sleep disturbance may contribute to diagnosis and treatment of subjective memory complaints in patients with epilepsy. Methods: Jenkins Sleep Scale (JSS), a validated sleep scale, was administered to consecutive new patients attending a dedicated epilepsy outpatient clinic based in a regional neuroscience centre, along with the five-point subjective memory complaint (SMC) Likert scale and a two-item mood screener. Results: Sleep disturbance identified using JSS was more frequent in patients with subjective memory complaint, as was mood disturbance (both p<0.02). Conclusion: Identifying sleep disturbance using a simple sleep screening scale may contribute to both diagnosis and treatment of subjective memory complaints in patients with epilepsy. ACKNOWLEDGEMENTNo sources of funding received.Aji BM, et al.

show abstract

Subjective sleep disturbance in Chinese adults with epilepsy: Associations with affective symptoms

Cited by 35 publications

References 64 publications

Insomnia in neurological diseases

Insomnia in neurological diseases

Perceived stress and sleep quality among the non-diseased general public in China during the 2019 coronavirus disease: a moderated mediation model

Cognitive Symptoms in Patients with Epilepsy: Role of Sleep and Mood Disturbance

Contact Info

Product

Resources

About